US Stock MarketDetailed Quotes
PRTG Portage Biotech
- 0.243
- -0.055-18.37%
Close Apr 23 16:00 ET
- 0.241
- -0.002-0.70%
Post 16:07 ET
4.80MMarket Cap-28P/E (TTM)
0.288High0.236Low165.89KVolume0.288Open0.297Pre Close43.21KTurnover1.62%Turnover RatioLossP/E (Static)19.78MShares4.40052wk High0.15P/B2.48MFloat Cap0.20052wk Low--Dividend TTM10.21MShs Float44.976Historical High--Div YieldTTM17.63%Amplitude0.200Historical Low0.260Avg Price1Lot Size
About Portage Biotech Company
Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.
Company Profile
SymbolPRTG
Company NamePortage Biotech
Listing DateFeb 25, 2021
Founded1973
CEODr. Ian B. Walters, M.D.
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
AddressClarence Thomas Building
CityRoad Town
ProvinceTortola
CountryVirgin Islands (British)
Zip CodeVG1110
Phone1-203-221-7378
Company Executives
- Name
- Position
- Salary
- Dr. Ian B. Walters, M.D.
- Chief Executive Officer and Chairman of the Board
- 1.72M
- Brian Wiley
- Chief Business Officer
- 339.03K
- Robert Kramer
- Chief Scientific Officer
- 447.61K
- Allan Lee Shaw
- Chief Financial Officer
- 873.39K
- Steven Innaimo
- Vice President of Project Management and Operations
- 520.69K
- Justin Fairchild
- Vice President of Development
- 790.46K
- Dr. Robert Glassman, M.D.
- Director
- 198.74K
- Steven M. Mintz
- Independent Director
- 96.48K
- Mark Simon
- Independent Director
- 90.98K
- James Mellon
- Independent Director
- 86.98K
- Linda Kozick
- Independent Director
- 91.48K
- Dr. Gregory Hugh Bailey
- Lead Independent Director
- 103.98K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg